• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[公平性与古巴国家卫生系统对新冠疫情的应对 古巴国家卫生系统对新冠疫情的公平性与应对措施]

[Equity and the Cuban National Health System's response to COVID-19Equidade e resposta do Sistema Nacional de Saúde de Cuba à pandemia de COVID-19].

作者信息

Mas Bermejo Pedro, Sánchez Valdés Lizet, Somarriba López Lorenzo, Valdivia Onega Nelly Cristina, Vidal Ledo María Josefina, Alfonso Sánchez Ileana, Seuc Jo Armando, Almeida Cruz Yudivian, Morales Ojeda Roberto

机构信息

Instituto de Medicina Tropical Pedro Kouri La Habana Cuba Instituto de Medicina Tropical Pedro Kouri, La Habana, Cuba.

Centro de Inmunología Molecular La Habana Cuba Centro de Inmunología Molecular, La Habana, Cuba.

出版信息

Rev Panam Salud Publica. 2020 Dec 15;44:e138. doi: 10.26633/RPSP.2020.138. eCollection 2020.

DOI:10.26633/RPSP.2020.138
PMID:33337442
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7737847/
Abstract

Cuba's National Health System has managed to guarantee an effective and equitable response to COVID-19. Universal and free health coverage, based on primary care, follows the principle of equity, and the greatest resources are allocated to areas of the lowest socioeconomic stratum (which concentrates the higher health risks), followed by those of medium and high strata, in that order. This allowed for similar mortality rates in the three strata, and Cuban national mortality rate was one of the lowest in the Region of the Americas. Before the first case was identified in Cuba, a Plan for Coronavirus Prevention and Control was elaborated with multisectoral participation, and when the first case was confirmed the Temporary Working Group to Fight COVID-19 was created as an advisory body of the government. The actions to face the pandemic began with preventive measures in the community, continued in the isolation centers and ended again in the community with actions of surveillance and follow up of recovered patients. Following the principle of territoriality, laboratories of molecular diagnosis were created in the provinces that did not have it. Free medical care and treatment; the preparation of a single national intersectoral government plan; the use of particular strategies for research, diagnosis and case tracing; and the implementation of a universal protocol for disease prevention and treatment of confirmed cases allowed to control the disease with a perspective of equity in health.

摘要

古巴国家卫生系统成功地确保了对新冠疫情作出有效且公平的应对。基于初级保健的全民免费医保遵循公平原则,最大份额的资源被分配到社会经济阶层最低的地区(该阶层集中了更高的健康风险),其次是中高阶层地区,依此顺序。这使得三个阶层的死亡率相近,古巴的全国死亡率是美洲地区最低的之一。在古巴确诊首例病例之前,就制定了一项由多部门参与的新冠病毒预防与控制计划,在首例病例确诊后,成立了抗击新冠疫情临时工作组作为政府的咨询机构。应对疫情的行动始于社区的预防措施,在隔离中心持续进行,并再次在社区以对康复患者的监测和跟踪行动告终。遵循属地原则,在没有分子诊断实验室的省份建立了此类实验室。免费医疗护理与治疗;制定单一的国家跨部门政府计划;采用特定的研究、诊断和病例追踪策略;以及实施针对确诊病例的疾病预防与治疗通用方案,这些举措得以从健康公平的角度控制住了疫情。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52d6/7737847/db99f1f3bfbd/rpsp-44-e138_Figure3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52d6/7737847/cbe3468bb72e/rpsp-44-e138_Figure1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52d6/7737847/1b5a21f52423/rpsp-44-e138_Figure2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52d6/7737847/db99f1f3bfbd/rpsp-44-e138_Figure3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52d6/7737847/cbe3468bb72e/rpsp-44-e138_Figure1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52d6/7737847/1b5a21f52423/rpsp-44-e138_Figure2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52d6/7737847/db99f1f3bfbd/rpsp-44-e138_Figure3.jpg

相似文献

1
[Equity and the Cuban National Health System's response to COVID-19Equidade e resposta do Sistema Nacional de Saúde de Cuba à pandemia de COVID-19].[公平性与古巴国家卫生系统对新冠疫情的应对 古巴国家卫生系统对新冠疫情的公平性与应对措施]
Rev Panam Salud Publica. 2020 Dec 15;44:e138. doi: 10.26633/RPSP.2020.138. eCollection 2020.
2
Equity and the Cuban National Health System's response to COVID-19.公平性与古巴国家卫生系统对新冠疫情的应对措施
Rev Panam Salud Publica. 2021 Jul 1;45:e80. doi: 10.26633/RPSP.2021.80. eCollection 2021.
3
A Collaboration to Teach US MPH Students about Cuba's Health Care System.中美合作教学:向美国公共卫生硕士学生介绍古巴的医疗体系
MEDICC Rev. 2018 Apr;20(2):49-53. doi: 10.37757/MR2018.V20.N2.11.
4
[Implementation of the plan of action for human resources for health and the COVID-19 pandemic responseImplementação do plano de ação sobre recursos humanos para a saúde e a resposta à pandemia de COVID-19].[《卫生人力资源行动计划与COVID-19大流行应对计划的实施》] (注:此翻译中“《》”是为了使标题格式更清晰,原英文标题中并无此符号,是根据中文习惯添加的) 关于卫生人力资源及对COVID-19大流行的应对行动计划的实施
Rev Panam Salud Publica. 2022 Jun 10;46:e52. doi: 10.26633/RPSP.2022.52. eCollection 2022.
5
Cuba's health care policy: prevention and active community participation.古巴的医疗保健政策:预防与社区积极参与。
Soc Work. 1990 Jan;35(1):29-35.
6
Cuban health system -- call it superior?古巴医疗体系——能称其为卓越吗?
Links. 1992 Spring;9(2):5-6.
7
[Transformations in the health system in Cuba and current strategies for its consolidation and sustainabilityTransformações no sistema de saúde em Cuba e estratégias atuais para sua consolidação e sustentabilidade].[古巴卫生系统的变革及其巩固与可持续发展的当前战略 古巴卫生系统的变革及其巩固与可持续发展的当前战略]
Rev Panam Salud Publica. 2018 Apr 24;42:e25. doi: 10.26633/RPSP.2018.25. eCollection 2018.
8
The Cuban health care system and factors currently undermining it.古巴的医疗保健系统及当前对其造成破坏的因素。
J Community Health. 1995 Aug;20(4):321-34. doi: 10.1007/BF02283057.
9
[Response capacity and challenges of the Cuban health system against communicable diseasesCapacidade de resposta e desafios do sistema de saúde cubano contra doenças transmissíveis].[古巴卫生系统应对传染病的能力与挑战 古巴卫生系统应对传染病的能力与挑战] (注:原文标题中重复部分未做特别区分,直接保留原文形式)
Rev Panam Salud Publica. 2018 Apr 24;42:e30. doi: 10.26633/RPSP.2018.30. eCollection 2018.
10
Human immunodeficiency virus in Cuba: the public health response of a Third World country.古巴的人类免疫缺陷病毒:一个第三世界国家的公共卫生应对措施
Int J Health Serv. 1991;21(3):511-37. doi: 10.2190/PPF0-X27G-LF4X-XEYC.

引用本文的文献

1
[Health equity and vulnerability in the access to COVID-19 vaccinesEquidad y vulnerabilidad en la salud respecto del acceso a las vacunas contra la COVID-19].[新冠疫苗接种方面的健康公平性与脆弱性 关于新冠疫苗接种的健康公平性与脆弱性]
Rev Panam Salud Publica. 2022 May 24;46:e31. doi: 10.26633/RPSP.2022.31. eCollection 2022.
2
Comparing the COVID-19 Responses in Cuba and the United States.比较古巴和美国的 COVID-19 应对措施。
Am J Public Health. 2021 Dec;111(12):2186-2193. doi: 10.2105/AJPH.2021.306526.
3
[Not Available].[无可用内容]。

本文引用的文献

1
COVID-19 in Cuba: Assessing the National Response.古巴的 COVID-19:评估国家应对措施。
MEDICC Rev. 2020 Oct;22(4):29-34. doi: 10.37757/MR2020.V22.N4.5.
2
COVID-19 reveals weak health systems by design: Why we must re-make global health in this historic moment.COVID-19 暴露出设计不良的薄弱卫生系统:为何我们必须在这一历史性时刻重塑全球卫生。
Glob Public Health. 2020 Jul;15(7):1083-1089. doi: 10.1080/17441692.2020.1760915. Epub 2020 Apr 30.
3
Biomodulina T partially restores immunosenescent CD4 and CD8 T cell compartments in the elderly.
Rev Panam Salud Publica. 2021 Aug 31;45:e99. doi: 10.26633/RPSP.2021.99. eCollection 2021.
4
[Not Available].[无可用内容]
Rev Panam Salud Publica. 2020 Dec 15;44:e167. doi: 10.26633/RPSP.2020.167. eCollection 2020.
5
Just societies: A new vision for health equity in the Americas after COVID-19.公正社会:新冠疫情后美洲地区健康公平的新愿景。
Rev Panam Salud Publica. 2020 Oct 29;44:e137. doi: 10.26633/RPSP.2020.137. eCollection 2020.
Biomodulina T 部分恢复老年免疫衰老的 CD4 和 CD8 T 细胞区室。
Exp Gerontol. 2019 Sep;124:110633. doi: 10.1016/j.exger.2019.110633. Epub 2019 Jun 14.
4
[Transformations in the health system in Cuba and current strategies for its consolidation and sustainabilityTransformações no sistema de saúde em Cuba e estratégias atuais para sua consolidação e sustentabilidade].[古巴卫生系统的变革及其巩固与可持续发展的当前战略 古巴卫生系统的变革及其巩固与可持续发展的当前战略]
Rev Panam Salud Publica. 2018 Apr 24;42:e25. doi: 10.26633/RPSP.2018.25. eCollection 2018.
5
HeberFERON, a new formulation of IFNs with improved pharmacodynamics: Perspective for cancer treatment.海博福源,一种新型的具有改良药效动力学的干扰素制剂:癌症治疗的新视角。
Semin Oncol. 2018 Jan;45(1-2):27-33. doi: 10.1053/j.seminoncol.2018.04.007. Epub 2018 May 4.
6
Therapeutic Targeting of CD6 in Autoimmune Diseases: A Review of Cuban Clinical Studies with the Antibodies IOR-T1 and Itolizumab.自身免疫性疾病中CD6的治疗靶点:古巴使用抗体IOR-T1和英夫利昔单抗的临床研究综述
Curr Drug Targets. 2016;17(6):666-77. doi: 10.2174/1389450117666160201114308.